Ganapathy Mohan

home / authors / ganapathy-mohan

Ganapathy Mohan, Ganapathy_mohan@merck.com, is executive director, global quality compliance, Merck & Co., Inc., Kenilworth, NJ, USA

Articles

Collaborative Efforts Address Key Data Integrity Challenges

Ganapathy Mohan;Christopher Turner ;Dennis O’Connor ;Lisa Fink ;Thomas Purdue ;Jeffrey Beebie;Kerri Robles ;Karen Waetjen

March 16th 2021

Maintaining a quality culture across the diverse functions in a bio/pharmaceutical company is difficult. Representatives of the Quality Coordinating Committee of IQ Consortium report on collaborative efforts to address data integrity and the modernization of FDA’s good laboratory practice regulations.

Pharmaceutical Stability: Scientific and Regulatory Considerations for Global Drug Development and Commercialization

Steven W. Baertschi, PhD;Mark Alasandro;Stephen Colgan;Saji Thomas;Dilip R. Choudhury;Bekki Komas;Robert H. Seevers;John Bobiak;David Lin;Robert J. Timpano;Ramesh K. Sood;Ganapathy Mohan;M. J. Skibic;Brian W. Pack;Kim Huynh-Ba

November 3rd 2012

A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.